Ruplizumab |
Catalog No.GC72360 |
Ruplizumab (BG 9588) est un anticorps monoclonal humanisé anti - CD40L (récepteur TNF) IgG1 Kappa.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 220651-94-5
Sample solution is provided at 25 µL, 10mM.
References:
[1]. Chris Chamberlain, et al. Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles. Ann Rheum Dis. 2017 Nov;76(11):1837-1844.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *